Clinical trial · Observational
How do I Perform a Laparoscopic Removal of a Pelvic Retroperitoneal Schwannoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Schwannomas are mainly benign tumors, which develop mainly in the skull or in the cervical region. Retroperitoneal location is rare, since it represents between 0.5 and 5% of scwhanomas. The malignant retroperitoneal form is, however, more common than in other locations. Retroperitoneal schwannoma is often discovered during the exploration of unexplained lumbo-pelvic pain, or in the face of compression of nearby organs. Abdominopelvic CT and magnetic resonance imaging are essential to characterize the mass and verify its extension. The precise diagnosis is based on the pathological examination of the part, and complete surgical excision is the standard treatment. Acquiring the surgical techniques and skills necessary to carry out these types of procedures is essential to providing optimal patient care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometriosis Pelvic | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- laparoscopic removal of a retroperitoneal pelvic schwannoma
- timeFrame
- Through study completion, an average of 1 month
- description
- The aim of this research is to train surgeons to perform laparoscopic removal of a retroperitoneal pelvic schwanoma
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patient (≥18 years old) * suffering from symptomatic deep pelvic endometriosis * having received treatment at the Strasbourg University Hospital during 2021 for a retro-peritoneal pelvic carcinoma * having not expressed, after information, the reuse of their data for the purposes of this research. Exclusion Criteria: * Patient who expressed her opposition to participating in the study
References
Publications (0)
Data not yet available